AIM: This pilot study aimed to compare muscle strength and quality of life (QOL) in cancer patients suffering from two different "typical male" cancer entities (prostate cancer and head and neck cancer). METHODS: The Biodex System 3 device was used for isokinetic strength testing of thigh muscles in both groups. QOL was evaluated by using the SF-36 Health Survey. RESULTS AND DISCUSSION: Surprisingly, prostate cancer patients showed significantly higher values for muscular strength of thigh muscles than significant younger patients with head and neck cancer. Furthermore, prostate cancer patients revealed significantly better values in QOL subscales "bodily pain" and "physical functioning".
AIM: This pilot study aimed to compare muscle strength and quality of life (QOL) in cancerpatients suffering from two different "typical male" cancer entities (prostate cancer and head and neck cancer). METHODS: The Biodex System 3 device was used for isokinetic strength testing of thigh muscles in both groups. QOL was evaluated by using the SF-36 Health Survey. RESULTS AND DISCUSSION: Surprisingly, prostate cancerpatients showed significantly higher values for muscular strength of thigh muscles than significant younger patients with head and neck cancer. Furthermore, prostate cancerpatients revealed significantly better values in QOL subscales "bodily pain" and "physical functioning".
Authors: Martijn M Stuiver; Cornelis P van Wilgen; Erlijn M de Boer; Cees J T de Goede; Muriel Koolstra; Anita van Opzeeland; Piet Venema; Margriet W Sterken; Andrew Vincent; Pieter U Dijkstra Journal: Otolaryngol Head Neck Surg Date: 2008-07 Impact factor: 3.497
Authors: Richard Crevenna; Georg Zettinig; Mohammad Keilani; Martin Posch; Manuela Schmidinger; Christian Pirich; Martin Nuhr; Michael Wolzt; Michael Quittan; Veronika Fialka-Moser; Robert Dudczak Journal: Support Care Cancer Date: 2003-06-03 Impact factor: 3.603
Authors: Manon G A van den Berg; Ellen L Rasmussen-Conrad; Lillian van Nispen; Jaap J van Binsbergen; Matthias A W Merkx Journal: Oral Oncol Date: 2008-02-20 Impact factor: 5.337
Authors: Liv Hege Aksnes; Kirsten Sundby Hall; Nina Jebsen; Sophie D Fosså; Alv A Dahl Journal: Support Care Cancer Date: 2007-03-09 Impact factor: 3.603
Authors: Mohammad Keilani; Christoph Krall; Christine Marosi; Birgit Flechl; Karin Dieckmann; Georg Widhalm; Maximilian Marhold; Richard Crevenna Journal: Wien Klin Wochenschr Date: 2012-06-12 Impact factor: 1.704
Authors: Michael K Ghiam; Kyle Mannion; Mary S Dietrich; Kristen L Stevens; Jill Gilbert; Barbara A Murphy Journal: Support Care Cancer Date: 2017-02-13 Impact factor: 3.603
Authors: Bruno Maehr; Mohammad Keilani; Christoph Wiltschke; Marco Hassler; Thomas Licht; Christine Marosi; Elisabeth Huetterer; Fadime Cenik; Richard Crevenna Journal: Wien Med Wochenschr Date: 2016-01-12
Authors: Mohammad Keilani; Franz Kainberger; Anna Pataraia; Timothy Hasenöhrl; Barbara Wagner; Stefano Palma; Fadime Cenik; Richard Crevenna Journal: Wien Klin Wochenschr Date: 2019-07-02 Impact factor: 1.704